Skip to main content
Erschienen in: Calcified Tissue International 1/2005

01.07.2005

Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women

verfasst von: A. L. Lauridsen, P. Vestergaard, A. P. Hermann, C. Brot, L. Heickendorff, L. Mosekilde, E. Nexo

Erschienen in: Calcified Tissue International | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

The major transporter of vitamin D metabolites in the circulation is the multifunctional plasma protein Gc, also known as group-specific component, Gc globulin, vitamin D–binding protein, or DBP. There are several phenotypes of Gc, and we examined the influence of Gc phenotype and Gc concentration on vitamin D status. By using isoelectric focusing we identified the Gc phenotype of 595 caucasian recent postmenopausal women enrolled into the Danish Osteoporosis Prevention Study (DOPS). We measured plasma concentration of Gc by immunonephelometry (coefficient of variation [CV] < 5%), 25-hydroxy vitamin D (25OHD) by a competitive protein-binding assay (CV 10%), and 1,25-dihydroxy-vitamin D (1,25(OH)2D) by a radioimmunoassay (CV 6–14%), and calculated index as the molar ratio of vitamin concentration divided by Gc concentration. Plasma levels of Gc, 25OHD, 25OHD index, and 1,25(OH)2D, but not 1,25(OH)2D index, differed significantly between women with different Gc phenotype, being highest in Gc1-1, intermediate in Gc1-2, and lowest in Gc2-2. In multiple regression analysis, Gc concentration was an independent predictor of 1,25(OH)2D, whereas Gc phenotype was a significant predictor of 25OHD concentration, even after adjustment for the effects of season, sunbathing habits, skin thickness, use of vitamin supplements, smoking, and body mass index (BMI). Plasma parathyroid hormone (PTH) level did not differ between Gc phenotypes. Despite the fact that more than 60% of the women with Gc phenotype Gc2-2 had plasma 25OHD levels of less than 50 nmol/L none of them had plasma PTH higher than reference limits. Bone mineral content (BMC), Bone mineral density (BMD), and bone markers did not differ between Gc phenotypes. In conclusion, plasma 1,25(OH)2D, 25OHD, and 25OHD index are related to Gc phenotype, and we speculate that the thresholds for vitamin D sufficiency differ between Gc phenotypes.
Literatur
1.
Zurück zum Zitat Braun, A, Bichlmaier, R, Cleve, H 1992Molecular analysis of the gene for the human vitamin-D–binding protein (group-specific component): allelic differences of the common genetic GC typesHum Genet89401406CrossRefPubMed Braun, A, Bichlmaier, R, Cleve, H 1992Molecular analysis of the gene for the human vitamin-D–binding protein (group-specific component): allelic differences of the common genetic GC typesHum Genet89401406CrossRefPubMed
2.
Zurück zum Zitat Lauridsen, AL, Vestergaard, P, Nexo, E 2001Mean serum concentration of vitamin D–binding protein (Gc globulin) is related to the Gc phenotype in womenClin Chem47753756PubMed Lauridsen, AL, Vestergaard, P, Nexo, E 2001Mean serum concentration of vitamin D–binding protein (Gc globulin) is related to the Gc phenotype in womenClin Chem47753756PubMed
3.
Zurück zum Zitat Lee, WM, Galbraith, RM 1992The extracellular actin-scavenger system and actin toxicityN Engl J Med32613351341PubMed Lee, WM, Galbraith, RM 1992The extracellular actin-scavenger system and actin toxicityN Engl J Med32613351341PubMed
4.
Zurück zum Zitat Baelen, H, Bouillon, R, Moor, P 1980Vitamin D–binding protein (Gc-globulin) binds actinJ Biol Chem25522702272PubMed Baelen, H, Bouillon, R, Moor, P 1980Vitamin D–binding protein (Gc-globulin) binds actinJ Biol Chem25522702272PubMed
5.
Zurück zum Zitat Kew, RR, Webster, RO 1988Gc-globulin (vitamin D–binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des ArgJ Clin Invest82364369PubMed Kew, RR, Webster, RO 1988Gc-globulin (vitamin D–binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des ArgJ Clin Invest82364369PubMed
6.
Zurück zum Zitat Schneider, GB, Benis, KA, Flay, NW, Ireland, RA, Popoff, SN 1995Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutationsBone16657662CrossRefPubMed Schneider, GB, Benis, KA, Flay, NW, Ireland, RA, Popoff, SN 1995Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutationsBone16657662CrossRefPubMed
7.
Zurück zum Zitat Yamamoto, N, Kumashiro, R 1993Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cellsJ Immunol15127942802PubMed Yamamoto, N, Kumashiro, R 1993Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cellsJ Immunol15127942802PubMed
8.
Zurück zum Zitat Daiger, SP, Schanfield, MS, Cavallisforza, LL 1975Group-specific component (Gc) proteins bind vitamin-D and 25-hydroxyvitamin-DProc Nat Acad Sci U S A7220762080 Daiger, SP, Schanfield, MS, Cavallisforza, LL 1975Group-specific component (Gc) proteins bind vitamin-D and 25-hydroxyvitamin-DProc Nat Acad Sci U S A7220762080
9.
Zurück zum Zitat Lips, P 2001Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implicationsEndocr Rev22477501CrossRefPubMed Lips, P 2001Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implicationsEndocr Rev22477501CrossRefPubMed
10.
Zurück zum Zitat Papapoulos, SE, Clemens, TL, Sandler, LM, Fraher, J, Winer, J, O’Riordan, JL 1982The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral doseClin Sci (Lond)62427429 Papapoulos, SE, Clemens, TL, Sandler, LM, Fraher, J, Winer, J, O’Riordan, JL 1982The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral doseClin Sci (Lond)62427429
11.
Zurück zum Zitat Davies, M, Heys, SE, Selby, PL, Berry, JL, Mawer, EB 1997Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone diseaseJ Clin Endocrinol Metab82209212CrossRefPubMed Davies, M, Heys, SE, Selby, PL, Berry, JL, Mawer, EB 1997Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone diseaseJ Clin Endocrinol Metab82209212CrossRefPubMed
12.
Zurück zum Zitat Bikle, DD, Siiteri, PK, Ryzen, E, Haddad, JG 1985Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levelsJ Clin Endocrinol Metab61969975PubMed Bikle, DD, Siiteri, PK, Ryzen, E, Haddad, JG 1985Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levelsJ Clin Endocrinol Metab61969975PubMed
13.
Zurück zum Zitat Bikle, DD, Gee, E, Halloran, B, Kowalski, MA, Ryzen, E, Haddad, JG 1986Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D–binding proteinJ Clin Endocrinol Metab63954959PubMed Bikle, DD, Gee, E, Halloran, B, Kowalski, MA, Ryzen, E, Haddad, JG 1986Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D–binding proteinJ Clin Endocrinol Metab63954959PubMed
14.
Zurück zum Zitat Lund, B, Sorensen, OH 1979Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish populationScand J Clin Lab Invest392330PubMed Lund, B, Sorensen, OH 1979Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish populationScand J Clin Lab Invest392330PubMed
15.
Zurück zum Zitat Lauridsen, AL, Vestergaard, P, Hermann, AP, Moller, HJ, Mosekilde, L, Nexo, E 2004Female premenopausal fracture risk is associated with Gc phenotypeJ Bone Miner Res19875878PubMed Lauridsen, AL, Vestergaard, P, Hermann, AP, Moller, HJ, Mosekilde, L, Nexo, E 2004Female premenopausal fracture risk is associated with Gc phenotypeJ Bone Miner Res19875878PubMed
16.
Zurück zum Zitat Aarskog, D, Aksnes, L, Markestad, T, Rodland, O 1983Effect of estrogen on vitamin D metabolism in tall girlsJ Clin Endocrinol Metab5711551158PubMed Aarskog, D, Aksnes, L, Markestad, T, Rodland, O 1983Effect of estrogen on vitamin D metabolism in tall girlsJ Clin Endocrinol Metab5711551158PubMed
17.
Zurück zum Zitat Dick, IM, Prince, RL, Kelly, JJ, Ho, KK 1995Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administrationClin Endocrinol (Oxf)43219224 Dick, IM, Prince, RL, Kelly, JJ, Ho, KK 1995Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administrationClin Endocrinol (Oxf)43219224
18.
Zurück zum Zitat Hoof, HJ, Sevaux, RG, Baelen, H, Swinkels, LM, Klipping, C, Ross, HA, Sweep, CG 2001Relationship between free and total 1,25-dihydroxyvitamm D in conditions of modified bindingEur J Endocrinol144391396CrossRefPubMed Hoof, HJ, Sevaux, RG, Baelen, H, Swinkels, LM, Klipping, C, Ross, HA, Sweep, CG 2001Relationship between free and total 1,25-dihydroxyvitamm D in conditions of modified bindingEur J Endocrinol144391396CrossRefPubMed
19.
Zurück zum Zitat Bouillon, R, Auwerx, J, Dekeyser, L, Fevery, J, Lissens, W, Moor, P 1984Serum vitamin D metabolites and their binding protein in patients with liver cirrhosisJ Clin Endocrinol Metab598689PubMed Bouillon, R, Auwerx, J, Dekeyser, L, Fevery, J, Lissens, W, Moor, P 1984Serum vitamin D metabolites and their binding protein in patients with liver cirrhosisJ Clin Endocrinol Metab598689PubMed
20.
Zurück zum Zitat Yamamoto, N, Homma, S 1991Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytesProc Natl Acad Sci USA8885398543PubMed Yamamoto, N, Homma, S 1991Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytesProc Natl Acad Sci USA8885398543PubMed
21.
Zurück zum Zitat Kawakami, M, Blum, CB, Ramakrishnan, R, Dell, RB, Goodman, DS 1981Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjectsJ Clin Endocrinol Metab5311101116PubMed Kawakami, M, Blum, CB, Ramakrishnan, R, Dell, RB, Goodman, DS 1981Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjectsJ Clin Endocrinol Metab5311101116PubMed
22.
Zurück zum Zitat Van den, BG, Roosbroeck, D, Vanhove, P, Wouters, PJ, Pourcq, L, Bouillon, R 2003Bone turnover in prolonged critical illness: effect of vitamin DJ Clin Endocrinol Metab8846234632CrossRefPubMed Van den, BG, Roosbroeck, D, Vanhove, P, Wouters, PJ, Pourcq, L, Bouillon, R 2003Bone turnover in prolonged critical illness: effect of vitamin DJ Clin Endocrinol Metab8846234632CrossRefPubMed
23.
Zurück zum Zitat Bouillon, R, Baelen, H, Moor, P 1980Comparative study of the affinity of the serum vitamin D–binding proteinJ Steroid Biochem1310291034CrossRefPubMed Bouillon, R, Baelen, H, Moor, P 1980Comparative study of the affinity of the serum vitamin D–binding proteinJ Steroid Biochem1310291034CrossRefPubMed
24.
Zurück zum Zitat Boutin, B, Galbraith, RM, Arnaud, P 1989Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin DJ Steroid Biochem325963CrossRefPubMed Boutin, B, Galbraith, RM, Arnaud, P 1989Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin DJ Steroid Biochem325963CrossRefPubMed
25.
Zurück zum Zitat Arnaud, J, Constans, J 1993Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP)Hum Genet92183188CrossRefPubMed Arnaud, J, Constans, J 1993Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP)Hum Genet92183188CrossRefPubMed
26.
Zurück zum Zitat Braun, A, Brandhofer, A, Cleve, H. 1990Interaction of the vitamin D–binding protein (group-specific component), its ligand 25-hydroxy-vitamin D3: binding differences of the various genetic types disclosed by isoelectric focusingElectrophoresis11478483CrossRefPubMed Braun, A, Brandhofer, A, Cleve, H. 1990Interaction of the vitamin D–binding protein (group-specific component), its ligand 25-hydroxy-vitamin D3: binding differences of the various genetic types disclosed by isoelectric focusingElectrophoresis11478483CrossRefPubMed
Metadaten
Titel
Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women
verfasst von
A. L. Lauridsen
P. Vestergaard
A. P. Hermann
C. Brot
L. Heickendorff
L. Mosekilde
E. Nexo
Publikationsdatum
01.07.2005
Erschienen in
Calcified Tissue International / Ausgabe 1/2005
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-004-0227-5

Weitere Artikel der Ausgabe 1/2005

Calcified Tissue International 1/2005 Zur Ausgabe

OriginalPaper

Announcements

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.